$3.34
0.22[7.05%]
At close: Apr 23
$3.34
0[0.00%]
PreMarket: 8:51AM EDT
CareMax
(NASDAQ:CMAX)CareMax Stock (NASDAQ:CMAX), Analyst Ratings, Price Targets, Predictions
CareMax Inc has a consensus price target of $8.48, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from UBS, UBS, and Piper Sandler on April 1, 2024, November 17, 2023, and November 10, 2023. With an average price target of $3.13 between UBS, UBS, and Piper Sandler, there's an implied -6.19% downside for CareMax Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
UBS
Piper Sandler
UBS
Truist Securities
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for CareMax
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/01/2024 | CMAX | Buy Now | CareMax | $3.34 | 91.62% | UBS | A.J. Rice | $7 → $6.4 | Maintains | Neutral | Get Alert |
| 11/17/2023 | CMAX | Buy Now | CareMax | $3.34 | -70.06% | UBS | A.J. Rice | $150 → $30 | Downgrade | Buy → Neutral | Get Alert |
| 11/10/2023 | CMAX | Buy Now | CareMax | $3.34 | -40.12% | Piper Sandler | Jessica Tassan | → $60 | Downgrade | Overweight → Neutral | Get Alert |
| 01/06/2023 | CMAX | Buy Now | CareMax | $3.34 | 79.64% | UBS | Andrew Mok | $300 → $180 | Maintains | Buy | Get Alert |
| 09/07/2022 | CMAX | Buy Now | CareMax | $3.34 | 124.55% | Truist Securities | Jailendra Singh | → $225 | Initiates | → Hold | Get Alert |
| 10/20/2021 | CMAX | Buy Now | CareMax | $3.34 | 349.1% | Jefferies | Brian Tanquilut | → $450 | Initiates | → Buy | Get Alert |
| 09/13/2021 | CMAX | Buy Now | CareMax | $3.34 | — | Piper Sandler | Jessica Tassan | — | Upgrade | Neutral → Overweight | Get Alert |
| 09/10/2021 | CMAX | Buy Now | CareMax | $3.34 | 319.16% | Cowen & Co. | Gary Taylor | → $420 | Initiates | → Outperform | Get Alert |
| 07/01/2021 | CMAX | Buy Now | CareMax | $3.34 | 319.16% | Piper Sandler | Jessica Tassan | → $420 | Initiates | → Neutral | Get Alert |
FAQ
What is the target price for CareMax (CMAX)?
The latest price target for CareMax (NASDAQ: CMAX) was reported by UBS on April 1, 2024. The analyst firm set a price target for $6.40 expecting CMAX to rise to within 12 months (a possible 91.62% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CareMax (CMAX)?
The latest analyst rating for CareMax (NASDAQ: CMAX) was provided by UBS, and CareMax maintained their neutral rating.
When was the last upgrade for CareMax (CMAX)?
The last upgrade for CareMax Inc happened on September 13, 2021 when Piper Sandler raised their price target to N/A. Piper Sandler previously had a neutral for CareMax Inc.
When was the last downgrade for CareMax (CMAX)?
The last downgrade for CareMax Inc happened on November 17, 2023 when UBS changed their price target from $5 to $1 for CareMax Inc.
When is the next analyst rating going to be posted or updated for CareMax (CMAX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareMax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareMax was filed on April 1, 2024 so you should expect the next rating to be made available sometime around April 1, 2025.
Is the Analyst Rating CareMax (CMAX) correct?
While ratings are subjective and will change, the latest CareMax (CMAX) rating was a maintained with a price target of $7.00 to $6.40. The current price CareMax (CMAX) is trading at is $3.34, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.